Cafiero T, Di Minno R M, Sivolella G, Di Iorio C
Department of Anesthesia, Postoperative Intensive Care, Burn Center and Hyperbaric Center A. Cardarelli Hospital, Naples, Italy.
Minerva Anestesiol. 2004 Sep;70(9):661-9.
The transition from intraoperative analgesia to postoperative analgesia must be planned carefully after remifentanil-based anesthesia, due to the short duration of action of remifentanil. The aim of this study is to compare the efficacy and safety of 2 transition strategies using sufentanil or tramadol for early postoperative pain relief in patients who had major abdominal surgery under general anesthesia with remifentanil/sevoflurane.
Sixty patients participated in this double-blind, prospective study and were randomly assigned to either sufentanil (S) group or tramadol (T) group. Twenty minutes before the end of surgery the patients received either a bolus of 0.15 microg kg(-1) sufentanil (group S) or tramadol 100 mg (group T). Mean arterial pressure (MAP), heart rate (HR) and rate pressure product (RPP=systolic arterial pressure (SAP)xHR), analgesia by a verbal rating score (VRS) and sedation by a sedation score (SS) were evaluated at emergence from anesthesia.
A statistically significant difference in HR between the 2 groups was recorded at extubation (78+/-13 in group S vs 86+/-24 in group T). A significant decrease of RPP values at extubation and 5 minutes later were found in group S in comparison with group T. VRS values were significantly lower in sufentanil group at 5 and 10 minutes after awakening.
Sufentanil provided more effective transition analgesia in comparison with tramadol. The effects of remifentanil dissipated rapidly and analgesia with major opioids was required. A bolus dose of sufentanil 0.15 microg kg(-1) was efficacious in controlling the hemodynamic parameters at awakening from anesthesia. The lower HR values and, consequently the lower RPP values are of utmost importance especially in the aged cardiovascular risk patient.
由于瑞芬太尼作用时间短,在以瑞芬太尼为基础的麻醉后,必须精心规划从术中镇痛到术后镇痛的过渡。本研究的目的是比较在全身麻醉下接受瑞芬太尼/七氟醚进行大腹部手术的患者中,使用舒芬太尼或曲马多的两种过渡策略对术后早期疼痛缓解的有效性和安全性。
60例患者参与了这项双盲前瞻性研究,并被随机分为舒芬太尼(S)组或曲马多(T)组。手术结束前20分钟,患者接受0.15微克/千克舒芬太尼推注(S组)或曲马多100毫克(T组)。在麻醉苏醒时评估平均动脉压(MAP)、心率(HR)和率压积(RPP = 收缩压(SAP)×HR)、通过语言评分量表(VRS)评估镇痛情况以及通过镇静评分(SS)评估镇静情况。
拔管时两组HR有统计学显著差异(S组为78±13,T组为86±24)。与T组相比,S组拔管时及5分钟后的RPP值显著降低。舒芬太尼组苏醒后5分钟和10分钟时VRS值显著更低。
与曲马多相比,舒芬太尼提供了更有效的过渡镇痛。瑞芬太尼的作用迅速消散,需要使用主要阿片类药物进行镇痛。0.15微克/千克的舒芬太尼推注剂量在控制麻醉苏醒时的血流动力学参数方面有效。较低的HR值以及相应较低的RPP值尤其对老年心血管风险患者至关重要。